Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2025 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2025 Earnings Call Transcript May 6, 2025Ultragenyx Pharmaceutical Inc. misses on earnings expectations.
Posts Tagged ‘NASDAQ:RARE’
Billionaire Stanley Druckenmiller’s Top 10 Stocks Picks with Huge Upside Potential
Wall Street is overflowing with data. If companies are not releasing their earnings, economic data flows almost daily.
11 Best Gene Therapy Stocks to Buy According to Analysts
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
10 Best Mid Cap Biotech Stocks to Buy
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2024 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2024 Earnings Call Transcript February 13, 2025Ultragenyx Pharmaceutical Inc. misses on earnings expectations.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q3 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to the Ultragenyx Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
What Makes Ultragenyx Pharmaceutical (RARE) an Exciting Investment Opportunity?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Mid-Cap Healthcare Stocks To Buy Now
According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Ultragenyx Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $-2.02505 EPS, expectations were $-1.72.
5 NASDAQ Stocks with Biggest Upside
Rivian Automotive, Inc. (NASDAQ:RIVN) manufactures and develops category-defining electric vehicles (EVs) and related accessories.
10 Biotech Stocks with Huge Potential
In this article, we will take a look at the 10 biotech stocks with huge potential.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2023 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc. beats earnings expectations. Reported EPS is $-1.52, expectations were $-1.65. Ultragenyx Pharmaceutical Inc.
15 Best Strong Buy Stocks To Invest In
In this piece, we will take a look at the 15 best strong buy stocks to invest in.
13 Most Promising Future Stocks To Buy According To Hedge Funds
In this piece, we will take a look at the 13 most promising stocks to buy according to hedge funds.
5 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 5 most promising biotech stocks to buy according to analysts.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Ultragenyx Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
5 Biotech Stocks with Biggest Upside
In this article, we discuss 5 biotech stocks with biggest upside.
10 Oversold Healthcare Stocks to Buy
In this article, we will take a look at the 10 healthcare stocks to buy.
15 Worst Performing Biotech Stocks in 2023
In this article, we discuss 15 worst performing biotech stocks in 2023.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Ultragenyx Second Quarter 2023 Financial Results Conference Call. [Operator Instructions].
5 Oversold Biotech Stocks to Buy
In this article, we will take a look at the 5 oversold biotech stocks to buy.
10 Best Economic Recovery Stocks to Buy
In this piece, we will take a look at the ten best economic recovery stocks to buy.
5 Best Revenue Growth Stocks to Buy
In this piece, we will take a look at the five best revenue growth stocks to buy.
13 Best Future Stocks for the Long-Term
Investing these days is a ride not for the faint hearted.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Ultragenyx First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
5 Most Promising Biotech Stocks According to Analysts
In this article, we discuss 5 most promising biotech stocks according to analysts.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2022 Financial Results Conference Call.
12 Stocks To Sell According to Motley Fool
In this article, we will be looking at 12 stocks to sell according to Motley Fool.
5 Stocks You Should Sell According to Motley Fool
In this article, we discuss 5 stocks you should sell according to Motley Fool.
Hedge Funds Are Dumping Ultragenyx Pharmaceutical Inc (RARE)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
10 Pharmaceutical Stocks to Buy Based on Billionaire Ken Griffin’s Portfolio
In this article, we discuss the top 10 pharmaceutical stocks to buy based on billionaire Ken Griffin’s portfolio.
Hedge Funds Are Piling Into Ultragenyx Pharmaceutical Inc (RARE)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is Ultragenyx Pharmaceutical Inc (RARE) A Good Stock To Buy?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Is RARE Stock A Buy or Sell?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
15 Fastest Growing Biotech Companies in the US
In this article we talk about 15 fastest growing biotech companies in the US.
Hedge Fund and Insider Trading News: Crispin Odey, Bill Ackman, Steve Cohen, Christopher Hohn, Ultragenyx Pharmaceutical Inc (RARE), Compass Diversified Holdings (CODI), and More
Crispin Odey’s flagship hedge fund lost money again in 2020, deepening the gloom for the bearish manager as he tries to revive his shrinking firm and fights an indecent assault...
Is RARE A Good Stock To Buy Now?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Hedge Fund and Insider Trading News: Ray Dalio, Ken Griffin, Bill Miller, Bill Ackman, Ultragenyx Pharmaceutical Inc (RARE), Caterpillar Inc. (CAT), and More
Bill Miller's Fund Crushed the Market for a Record 15 Straight Years.
Here is What Hedge Funds Think About Ultragenyx Pharmaceutical Inc (RARE)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Did Hedge Funds Make The Right Call On Ultragenyx Pharmaceutical Inc (RARE) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file ...
Ultragenyx Pharmaceutical Inc (RARE): Hedge Funds In Wait-and-See Mode
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Hedge Fund and Insider Trading News: David Gerstenhaber, Bill Ackman, Visium Asset Management, Citadel LLC, Egerton Capital, Ultragenyx Pharmaceutical Inc (RARE), II-VI, Inc. (IIVI), and More
A judge has dismissed a lawsuit brought by a hedge fund against the widow of one of the fund’s employees.
Hedge Funds Were Selling Ultragenyx Pharmaceutical Inc (RARE) Before The Coronavirus
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Do Hedge Funds Love Ultragenyx Pharmaceutical Inc (RARE)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Were Hedge Funds Right About Dumping Ultragenyx Pharmaceutical Inc (RARE)?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Hedge Fund and Insider Trading News: John Paulson, Daniel Loeb, Tom Steyer, GoldenTree Asset Management, Fox Factory Holding Corp (FOXF), Silicon Laboratories (SLAB), and More
When President Trump returns to New York City to speak at the United Nations next week, he will be having a fundraiser at the luxurious Upper East Side townhouse of legendary ...
Here’s What Hedge Funds Think About Ultragenyx Pharmaceutical Inc (RARE)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
